Literature DB >> 853604

Serum immune complexes in membranoproliferative and other glomerulonephritides.

Y M Ooi, E H Vallota, C D West.   

Abstract

Immune complexes were detected in the serum of patients with membranoproliferative glomerulonephritis (MPGN) Types I and II, systemic lupus erythematosus (SLE), and acute poststreptococcal glomerulonephritis (AGN) by sucrose gradient ultracentrifugation and by measurement of Clq binding activity (Clq-BA). Clq-BA was more sensitive in detecting complexes than was gradient ultracentrifugation. By gradient ultracentrifugation, the sedimentation velocities of the complexes in the three diseases were similar, ranging from 13S to 19S. This range corresponds to that observed by others in experimental chronic serum sickness nephritis. The complexes isolated by gradient ultracentrifugation always contained C3, usually IgG and C4, and in some patients with SLE and AGN, IgM. In MPGN, IgM and IgA could be present in glomerular deposits when not present in circulating complexes. In this disease also, serum complement levels were poor predictors of the presence of complexes. With increased Clq-BA, the levels of Clq, C4, and C2 could be normal or reduced and there was no correlation with C3 levels. With few exceptions, the clinical status of the patients with MPGN correlated well with Clq-BA.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 853604     DOI: 10.1038/ki.1977.41

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  10 in total

1.  Circulating and deposited immune complexes in renal disease and their clinical correlation.

Authors:  S L Cohen; C Fisher; J F Mowbray; A Hopp; J Burton-Kee
Journal:  J Clin Pathol       Date:  1979-11       Impact factor: 3.411

Review 2.  Immune complexes in human diseases: a review.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Am J Pathol       Date:  1980-08       Impact factor: 4.307

3.  Serum-mediated inhibition of lymphocyte Fc gamma receptors in glomerulonephritis.

Authors:  A Bakkaloglu; G P Sandilands; J D Briggs; J R Anderson
Journal:  Clin Exp Immunol       Date:  1980-12       Impact factor: 4.330

4.  Serial studies on circulating immune complexes in post-streptococcal sequelae.

Authors:  I van de Rijn; H Fillit; W E Brandeis; H Reid; T Poon-King; M McCarthy; N K Day; J B Zabriskie
Journal:  Clin Exp Immunol       Date:  1978-12       Impact factor: 4.330

5.  Application of the solid phase C1q and Raji cell radioimmune assays for the detection of circulating immune complexes in glomerulonephritis.

Authors:  K S Tung; A J Woodroffe; T D Ahlin; R C Williams; C B Wilson
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

6.  Humoral immunity to streptococcal antigen in acute and chronic glomerulonephritis.

Authors:  M Krzymański; K Falkiewicz; W Kopeć; K Baczyk; Z Szewczyk
Journal:  Int Urol Nephrol       Date:  1982       Impact factor: 2.370

7.  Circulating immune complexes after renal transplantation. Correlation of increased 125I-Clq binding activity with acute rejection characterized by fibrin deposition in the kidney.

Authors:  Y M Ooi; B S Ooi; E H Vallota; M R First; V E Pollak
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

8.  Diminished synthesis of immunoglobulin by peripheral lymphocytes of patients with idiopathic membranous glomerulonephropathy.

Authors:  B S Ooi; Y M Ooi; A Hsu; P E Hurtubise
Journal:  J Clin Invest       Date:  1980-04       Impact factor: 14.808

9.  Circulating and tissue-bound immune complexes in allergic vasculitis: relationship between immunoglobulin class and clinical features.

Authors:  R H Kauffmann; W A Herrmann; C J Meijer; M R Daha; L A Vanes
Journal:  Clin Exp Immunol       Date:  1980-09       Impact factor: 4.330

10.  Modification of glomerular immune complex deposition in mice by activation of the reticuloendothelial system.

Authors:  U Barcelli; R Rademacher; Y M Ooi; B S Ooi
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.